1. Home
  2. BBGI vs MRKR Comparison

BBGI vs MRKR Comparison

Compare BBGI & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

HOLD

Current Price

$8.80

Market Cap

20.6M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

19.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
MRKR
Founded
1961
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
19.5M
IPO Year
1999
2010

Fundamental Metrics

Financial Performance
Metric
BBGI
MRKR
Price
$8.80
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
29.3K
★ 81.4K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
★ 48.01
N/A
Revenue
★ $232,179,463.00
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
$0.47
$375.85
P/E Ratio
$0.18
★ N/A
Revenue Growth
★ 69.89
N/A
52 Week Low
$3.14
$0.84
52 Week High
$29.30
$2.46

Technical Indicators

Market Signals
Indicator
BBGI
MRKR
Relative Strength Index (RSI) 22.56 49.50
Support Level $3.50 N/A
Resistance Level $24.70 $1.34
Average True Range (ATR) 1.29 0.08
MACD -0.14 -0.00
Stochastic Oscillator 12.98 59.38

Price Performance

Historical Comparison
BBGI
MRKR

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA; Augusta, GA; Boston, MA; Charlotte, NC; Detroit, MI; Fayetteville, NC; Fort Myers-Naples, FL; Las Vegas, NV; Middlesex, NJ; Monmouth, NJ; Morristown, NJ; Philadelphia, PA; Tampa-Saint Petersburg, FL; and Wilmington, DE. The company operates in two segments: Audio, which generates the maximum revenue, and Digital.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: